Quadrant Biosciences Inc.
PrivateLast Round
Series B
Aug 8, 2023
Est. Valuation
$266.98M
Total Funding Raised
$10.55M
Company Overview
Quadrant Biosciences Inc. operates in Healthcare & Life Sciences and is based in Syracuse, New York. Its latest recorded funding round was a Series B round in August 2023.
Quadrant Biosciences Inc. is a biotechnology company that develops epigenetic diagnostics for the early detection and diagnosis of neurological and developmental disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Telemedicine, Precision Medicine, Mental Health, Environmental Monitoring
Business Model
B2C
Customer Profile
Services & Consulting, Government Contracts, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Quadrant Biosciences Inc. Comparables
Compare Quadrant Biosciences Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cognoa | 78% | |
| MARAbio | 76% | |
| EarliPoint Health | 70% |
For institutional investors. Book with your work email.
Quadrant Biosciences Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 8, 2023 | ||||
| Crowdfunding | Aug 15, 2020 | ||||
| Debt | May 1, 2020 | ||||
| Debt | May 1, 2020 | ||||
| Grant | Jun 19, 2019 | ||||
Grant | Sep 19, 2018 |
For institutional investors. Book with your work email.
Quadrant Biosciences Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| JPMorgan Chase & Co. | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2020
$756K round with J.P. Morgan
- May 1, 2020
$160K debt round completed.
For institutional investors. Book with your work email.
Quadrant Biosciences Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Quadrant Biosciences Inc.'s valuation, stock price, and market status.
Is Quadrant Biosciences Inc. a public or private company?
Quadrant Biosciences Inc. is a private company.
What is the current stock price of Quadrant Biosciences Inc.?
Quadrant Biosciences Inc. is a private company, so its shares have no public market price. Caplight tracks Quadrant Biosciences Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Quadrant Biosciences Inc. worth (valuation)?
Quadrant Biosciences Inc.'s valuation is estimated at $267.0M based on funding round data.
Can I buy Quadrant Biosciences Inc. stock?
Quadrant Biosciences Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Quadrant Biosciences Inc.'s last funding round?
Quadrant Biosciences Inc.'s most recent funding round was Series B on August 8, 2023.
Who are the main investors in Quadrant Biosciences Inc.?
Key investors in Quadrant Biosciences Inc. include NIH RADx, JPMorgan Chase & Co..
Will Quadrant Biosciences Inc. IPO soon?
No public IPO plans have been announced for Quadrant Biosciences Inc..
How can I track Quadrant Biosciences Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Quadrant Biosciences Inc.'s shares on secondary markets.